Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide

Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide: Investigation of Disruptive Mood Dysregulation Disorder

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02803632

Acronym

ACTIHUMEUR

Enrollment

Registered

2016-06-17

Start date

2013-02-06

Completion date

2018-08-24

Last updated

2020-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide, Attempted

Keywords

young, disruptive mood dysregulation disorder, actigraphic profile

Brief summary

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the \> 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit

Detailed description

An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the \> 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit. New approaches have been proposed to these problems that have led us to reorganize our diagnostic practices: 1) more precise characterization of suicidal behaviour by using standardized instruments such as the French version of the Columbia-Suicide Severity Rating Scale developed by Posner (C-SSRS); 2) new clinical entities, such as disruptive mood dysregulation disorder, are now proposed in international classifications (DSM 5 field trial); 3) investigations such as recording of the circadian rhythm of motor activity by actigraphy are being studied as a laboratory complement to psychiatric diagnosis.

Interventions

BEHAVIORALquestionnaires

DEVICEactigraphic recording

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to 17 Years

Healthy volunteers

Inclusion criteria

* children/adolescents admitted after a suicide attempt

Exclusion criteria

* severe depression * mental retardation * pervasive developmental disorder * active psychotic episode, * drug and alcohol abuse at the time of admission * organic sleep-wake disorders (sleep-related respiratory and motor disorders, narcolepsy) * any contraindication formulated by the clinical team * patients not covered by French national health insurance, patients deprived of their freedom as stipulated in Article L.1121-6 of the French Public Health Code

Design outcomes

Primary

Measure	Time frame	Description
The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)	Day 0	The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026